As of 2024-12-14, the Intrinsic Value of Xylem Inc (XYL) is
129.31 USD. This Xylem valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 120.60 USD, the upside of Xylem Inc is
7.20%.
The range of the Intrinsic Value is 86.80 - 257.61 USD
129.31 USD
Intrinsic Value
Xylem Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
86.80 - 257.61 |
129.31 |
7.2% |
| DCF (Growth 10y) |
118.75 - 332.71 |
172.37 |
42.9% |
| DCF (EBITDA 5y) |
113.41 - 146.49 |
128.16 |
6.3% |
| DCF (EBITDA 10y) |
138.69 - 190.14 |
161.35 |
33.8% |
| Fair Value |
40.44 - 40.44 |
40.44 |
-66.47% |
| P/E |
79.92 - 97.78 |
89.87 |
-25.5% |
| EV/EBITDA |
90.24 - 144.69 |
112.65 |
-6.6% |
| EPV |
24.71 - 34.40 |
29.56 |
-75.5% |
| DDM - Stable |
33.91 - 124.75 |
79.33 |
-34.2% |
| DDM - Multi |
78.06 - 216.24 |
113.89 |
-5.6% |
Xylem Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
29,298.56 |
| Beta |
1.20 |
| Outstanding shares (mil) |
242.94 |
| Enterprise Value (mil) |
30,303.56 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.76% |
| Cost of Debt |
4.25% |
| WACC |
8.39% |